← Open Payments lookup

KATHY BERNSTEIN: Open Payments

NPI 1144642091 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,519 in 66 payments from 20 companies in 2025. Trend: 2023 $1,016 · 2024 $1,707 · 2025 $1,519

Food & beverage: $1,432Education: $88
CompanyPaymentsAmount
BETA BIONICS, INC.7$223
Dexcom, Inc.8$197
Xeris Pharmaceuticals, Inc.10$188
Abbott Laboratories5$175
Novo Nordisk Inc10$165
Mannkind Corporation4$92
Lilly USA, LLC3$79
PFIZER INC.3$59
Ascendis Pharma Endocrinology Inc3$57
Amgen Inc.2$45

Products named: iLet Bionic Pancreas, Dexcom G6 Transmitter, GVOKE HYPOPEN, FREESTYLE LIBRE 3, Ozempic, AFREZZA, PREVNAR 20, Yorvipath.

Industry payments across LA — which companies pay providers there.